Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -186.95% is 37% above its 5-year average of -296.80%, near the high end of its 5-year range (-853.10%–-38.70%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.87% above its 12-month average of -270.44%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -186.95%.
RETURN ON EQUITY (ROE)
-186.95%
RETURN ON EQUITY (ROE) AVG TTM
-270.44%
RETURN ON EQUITY (ROE) AVG 3Y
-303.33%
RETURN ON EQUITY (ROE) AVG 5Y
-296.80%
RETURN ON EQUITY (ROE) AVG 10Y
-233.31%
RETURN ON EQUITY (ROE) AVG 15Y
-221.07%
RETURN ON EQUITY (ROE) AVG 20Y
-221.64%
CURRENT VS TTM AVG
+30.87%
CURRENT VS 3Y AVG
+38.37%
CURRENT VS 5Y AVG
+37.01%
CURRENT VS 10Y AVG
+19.87%
CURRENT VS 15Y AVG
+15.43%
CURRENT VS 20Y AVG
+15.65%
SECTOR MEDIAN · HEALTHCARE
-40.21%
median of 529 covered companies
CURRENT VS SECTOR MEDIAN
-364.94%
vs the sector median at left
Vyome Holdings, Inc.
Market Cap
$13.72M
Return on Equity (ROE)
-186.95%
TTM Avg
-270.44%
3Y Avg
-303.33%
5Y Avg
-296.80%
Market Cap
$13.94M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.98M
Return on Equity (ROE)
-69.47%
TTM Avg
-55.64%
3Y Avg
-44.95%
5Y Avg
-41.56%
Market Cap
$13.62M
Return on Equity (ROE)
-101.66%
TTM Avg
-140.38%
3Y Avg
-131.64%
5Y Avg
-101.94%
Market Cap
$12.78M
Return on Equity (ROE)
-74.73%
TTM Avg
-265.78%
3Y Avg
-138.63%
5Y Avg
-109.18%
Market Cap
$14.44M
Return on Equity (ROE)
N/A
TTM Avg
54.00%
3Y Avg
301.36%
5Y Avg
162.15%
Market Cap
$15.04M
Return on Equity (ROE)
-42.72%
TTM Avg
-65.53%
3Y Avg
-58.02%
5Y Avg
-43.63%
Market Cap
$12.58M
Return on Equity (ROE)
N/A
TTM Avg
-201.97%
3Y Avg
-21.23%
5Y Avg
365.72%
Market Cap
$12.41M
Return on Equity (ROE)
-97.47%
TTM Avg
-90.15%
3Y Avg
-205.18%
5Y Avg
-136.35%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vyome Holdings, Inc. (HIND) | $13.72M | -186.95% | -270.44% | -303.33% | -296.80% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.94M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.98M | -69.47% | -55.64% | -44.95% | -41.56% |
| IN8bio, Inc. (INAB)vs › | $13.62M | -101.66% | -140.38% | -131.64% | -101.94% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | -74.73% | -265.78% | -138.63% | -109.18% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.44M | N/A | 54.00% | 301.36% | 162.15% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | -42.72% | -65.53% | -58.02% | -43.63% |
| Dare Bioscience, Inc. (DARE)vs › | $12.58M | N/A | -201.97% | -21.23% | 365.72% |
| IRIDEX Corporation (IRIX)vs › | $12.41M | -97.47% | -90.15% | -205.18% | -136.35% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | -951.92% | -161.65% | -122.41% | -87.71% |
ROE
-187.0%
ROA
-123.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -186.95% |
| 2026-03-31 | -196.50% |
| 2025-12-31 | -442.88% |
| 2025-09-30 | -448.70% |
| 2025-06-30 | -77.17% |
| 2025-03-31 | -281.54% |
| 2024-09-30 | -475.25% |
| 2024-06-30 | -297.20% |
| 2024-03-31 | -240.80% |
| 2023-12-31 | -170.90% |
| 2023-09-30 | -853.10% |
| 2023-06-30 | -518.74% |
| 2023-03-31 | -527.25% |
| 2022-09-30 | -311.81% |
| 2022-06-30 | -218.82% |
| 2022-03-31 | -168.99% |
| 2021-12-31 | -139.70% |
| 2021-09-30 | -44.19% |
| 2021-06-30 | -38.70% |
| 2021-03-31 | -174.64% |
| 2020-12-31 | -149.30% |
| 2020-09-30 | -223.33% |
| 2020-06-30 | -322.28% |
| 2020-03-31 | -343.30% |
| 2019-12-31 | -307.82% |
| 2019-06-30 | -411.17% |
| 2019-03-31 | -260.37% |
| 2018-12-31 | -256.30% |
| 2018-09-30 | -175.06% |
| 2018-06-30 | -169.00% |
| 2018-03-31 | -57.21% |
| 2017-12-31 | -44.28% |
| 2017-09-30 | -56.10% |
| 2017-06-30 | -66.21% |
| 2017-03-31 | -129.94% |
| 2016-12-31 | -794.86% |
| 2015-12-31 | -694.24% |
| 2015-09-30 | -321.73% |
| 2015-03-31 | -363.23% |
| 2014-12-31 | -392.08% |
| 2014-09-30 | -253.38% |
| 2014-06-30 | -184.76% |
| 2014-03-31 | -150.49% |
| 2013-12-31 | -175.63% |
| 2013-09-30 | -211.55% |
| 2013-06-30 | -186.23% |
| 2013-03-31 | -130.51% |
| 2012-12-31 | -197.57% |
| 2012-09-30 | -145.67% |
| 2012-06-30 | -150.89% |
| 2012-03-31 | -175.42% |
| 2011-12-31 | -129.72% |
| 2011-09-30 | -80.31% |
| 2011-06-30 | -92.94% |
| 2011-03-31 | -70.08% |
| 2010-12-31 | -58.39% |
| 2010-09-30 | -285.25% |
| 2010-06-30 | -824.47% |
| 2010-03-31 | -490.13% |
| 2009-12-31 | -572.10% |
| 2009-06-30 | -377.16% |
| 2009-03-31 | -190.64% |
| 2008-12-31 | -332.08% |
| 2008-09-30 | -225.94% |
| 2008-06-30 | -131.39% |
| 2008-03-31 | -81.47% |
| 2007-12-31 | -63.11% |
| 2007-09-30 | -192.69% |
| 2006-12-31 | -61.91% |
| 2005-12-31 | -567.99% |
